Arca
Skip to content
Tools
Tools

Keratitis

Drug research and approvals for keratitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 22 studies of keratitis are recruiting on ClinicalTrials.gov, Health Canada has authorized 2 drug trials for it since 2013, FDA has 5 approved and 16 open orphan designations naming it, and the EU has 3 authorised medicines for it.

  • Recruiting worldwide: 22
  • Trials authorized in Canada: 2
  • FDA orphan approvals: 5
  • EU medicines: 3

Recruiting now

Newest posted first, of 22 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 6

Phase 3 4

Phase 1 or earlier 2

How its trials ended

143 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 33 whose ending is known, 42% met their primary endpoint, 0% missed it and 58% stopped early.

  • Completed, result not reported5538%
  • Ongoing2920%
  • Status unknown2618%
  • Met its primary endpoint1410%
  • Stopped: other or unclear128%
  • Stopped: enrollment or feasibility43%
  • Stopped: lack of efficacy32%

Trials authorized in Canada

Newest first; search them all in Canada trials
Jul 12, 2022A multi-center, randomized, double-masked, vehicle-controlled, parallel-group, study to evaluate the safety and efficacy of CSB-001 ophthalmic solution 0.1% in…CSB-001Claris BiotherapeuticsOngoing
Nov 26, 2021Topical insulin drops for the treatment of neurotrophic keratopathyHumulin-rGovernors of The University of AlbertaClosed

FDA orphan designations

Approved first, then open designations, newest first; 15 of 21
Mar 29, 2019AvaclyrAVACLYR is a sterile topical antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes…Fera PharmaceuticalsApproved
Aug 22, 2018OxervateTreatment of neurotrophic keratitisDompe S.p.A.Approved
Sep 15, 2009ZirganTreatment of acute herpetic keratitis (dendritic ulcers)Sirion Therapeutics, Inc.Approved
Feb 18, 2005Vaccinia Immune Globulin (Human) IntravenousTreatment and modification of aberrant infections induced by vaccinia virus that include its accidental implantation in eyes (except in…DynPort Vaccine Company LLCApproved
Sep 23, 1993Alomide Ophthalmic SolutionTreatment of ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis.Alcon Laboratories, Inc.Approved
Jul 14, 2026Pathogen-inactivated allogeneic human growth factorTreatment of neurotrophic keratitisEye Care International LLCDesignated
Jul 14, 2026TavilermideTreatment of neurotrophic keratitis (NK)Mimetogen Pharmaceuticals, Inc.Designated
Mar 17, 2025Povidone iodineTreatment of fungal keratitisIVIEW Therapeutics, IncDesignated
Dec 18, 2024LacripepTreatment of neurotrophic keratitisTearSolutions Inc.Designated
Sep 30, 2024Allogeneic human blood serumTreatment of neurotrophic keratitisAllovision, LLCDesignated
Jul 20, 2023MeropenemTreatment of bacterial keratitisIbiotica, LLCDesignated
Jul 5, 2023Exosomes purified from primed human bone marrow derived…Treatment of neurotrophic keratitisPandorum Technologies, Inc.Designated
Nov 28, 2022Pigment Epithelium Derived Factor derived short peptide…Treatment of Neurotrophic KeratitisBRIM BiotechnologyDesignated
Jun 24, 2022HSV-1-erasing lentivirus-like particle delivering…Treatment of herpes simplex (HSV-1) infected keratitis (HSK)Hangzhou BDgene Co., Ltd.Designated
Feb 11, 2022PolihexanideTreatment of fungal keratitis infectionSIFI SpADesignated

Medicines authorised in the EU

Newest first
Aug 22, 2024AkantiorPolihexanide · orphanSifi SpaEMA ↗
Jul 6, 2017OxervateCenegermin · orphanDompe' Farmaceutici S.p.A.EMA ↗
Mar 19, 2015IkervisCiclosporinSanten OyEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.